Chongqing Zhifei Biological Products Co.,Ltd.(300122),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

300122 Chongqing Zhifei Biological Products Co.,Ltd.

Closed 01-26 15:00:00

19.85

+2.57

+14.87%

High20.40	Low17.55	Vol124.06M
Open17.55	D1 Closing17.28	Amplitude16.49%
Mkt Cap47.52B	Tradable Cap28.07B	Total Shares2.39B
T/O2.36B	T/O Rate8.77%	Tradable Shares1.41B
P/B1.41	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"300122","market":"SZ","secType":"STK","nameCN":"Chongqing Zhifei Biological Products Co.,Ltd.","latestPrice":19.85,"timestamp":1769411010000,"preClose":17.28,"halted":0,"volume":124059544,"delay":0,"changeRate":0.1487,"floatShares":1414000000,"shares":2394000000,"eps":-0.5592,"marketStatus":"Closed","change":2.57,"latestTime":"01-26 15:00:00","open":17.55,"high":20.4,"low":17.55,"amount":2364000000,"amplitude":0.1649,"askPrice":19.85,"askSize":1874,"bidPrice":19.84,"bidSize":3186,"shortable":0,"etf":0,"ttmEps":-0.5592,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769477400000},"marketStatusCode":5,"adr":0,"adjPreClose":17.28,"symbolType":"stock","openAndCloseTimeList":[[1769391000000,1769398200000],[1769403600000,1769410800000]],"highLimit":19.01,"lowLimit":15.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2393789747,"isCdr":false,"pbRate":1.41,"roa":"--","roe":"--","epsLYR":0.8427,"committee":-0.11253,"marketValue":47517000000,"turnoverRate":0.0877,"status":0,"floatMarketCap":28074000000},"requestUrl":"/m/hq/s/300122/tweets","defaultTab":"tweets","newsList":[{"id":"1159731186","title":"Zhifei Biological Faces Over 10 Billion Yuan Loss in 2025, Urgently Seeks 10.2 Billion Yuan Syndicated Loan to Survive","url":"https://stock-news.laohu8.com/highlight/detail?id=1159731186","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159731186?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:02","pubTimestamp":1768899726,"startTime":"0","endTime":"0","summary":"Once a high-flyer due to its distribution rights for Merck's HPV vaccine, Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) is now confronting its most severe operational crisis since...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0077","LU1328615791.USD","LU2148510915.USD","BK0046","BK0196","LU1064131003.USD","LU2580892789.USD","300122","LU1064130708.USD","LU2580892862.HKD","BK0239"],"gpt_icon":0},{"id":"1121212456","title":"Anticipated Loss of 10.7-13.7 Billion Yuan for 2025! Zhifei Biological: The Darkest Hour for the \"Vaccine King\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1121212456","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121212456?lang=en_us&edition=fundamental","pubTime":"2026-01-19 18:22","pubTimestamp":1768818171,"startTime":"0","endTime":"0","summary":"Investing in stocks requires reading Golden Kirin analyst reports, which are authoritative, professional, timely, and comprehensive, helping you uncover potential thematic opportunities! Is this a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","159646","LU1064131003.USD","BK0196","LU1328615791.USD","BK0077","BK0188","LU2148510915.USD","LU2580892789.USD","LU1064130708.USD","LU2580892862.HKD","300122","BK0046"],"gpt_icon":0},{"id":"1157723431","title":"Massive Loss of 10 Billion! Zhifei's HPV Vaccine Agency Shifts from Easy Wins to Crushing Defeats—Who Bears the Cost for Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=1157723431","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157723431?lang=en_us&edition=fundamental","pubTime":"2026-01-18 21:42","pubTimestamp":1768743720,"startTime":"0","endTime":"0","summary":"Scientists believe cervical cancer may become the first cancer ever conquered in human history. Modern science confirms that cervical cancer is primarily caused by lesions from several high-risk HPV...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0196","BK0046","LU1064130708.USD","300122","LU1064131003.USD","BK0077","LU1328615791.USD","LU2580892862.HKD","BK0188","LU2580892789.USD","159646","LU2148510915.USD"],"gpt_icon":0},{"id":"1132327116","title":"Zhifei Biological Secures 10 Billion Yuan Loan Amid Survival Struggle, Vaccine Industry Reshuffle Looms","url":"https://stock-news.laohu8.com/highlight/detail?id=1132327116","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132327116?lang=en_us&edition=fundamental","pubTime":"2026-01-16 17:21","pubTimestamp":1768555264,"startTime":"0","endTime":"0","summary":"On the evening of January 5, 2026, A-share vaccine leader Chongqing Zhifei Biological Products Co.,Ltd. announced plans to apply for medium to long-term loans totaling no more than 10.2 billion yuan,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","BK0077","LU1064130708.USD","LU2580892862.HKD","LU2580892789.USD","159646","LU2148510915.USD","BK0239","300122","BK0188","LU1328615791.USD","BK0196","BK0046"],"gpt_icon":0},{"id":"1120192712","title":"Zhifei Biotech Demonstrates Strategic Resolve Amidst Performance Pressure, Innovation Transformation and Global Expansion Build Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1120192712","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120192712?lang=en_us&edition=fundamental","pubTime":"2026-01-15 10:51","pubTimestamp":1768445513,"startTime":"0","endTime":"0","summary":"In 2025, the global vaccine industry continues to face pressure amidst multiple challenges including fluctuating vaccination willingness, policy adjustments, and homogenized competition, leading to a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","BK0196","LU1328615791.USD","LU1064131003.USD","300122","BK0077","LU2580892789.USD","LU1064130708.USD","LU2148510915.USD","BK0188","LU2580892862.HKD","BK0239"],"gpt_icon":0},{"id":"1189384307","title":"Zhifei Biological's 10-Billion-Yuan Loss: Financial Bathing Suspected? Short-Term Woes with 10-Billion-Yuan Debt Burden","url":"https://stock-news.laohu8.com/highlight/detail?id=1189384307","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189384307?lang=en_us&edition=fundamental","pubTime":"2026-01-14 18:06","pubTimestamp":1768385209,"startTime":"0","endTime":"0","summary":"The massive 10-billion-yuan loss reported by Zhifei Biological has drawn significant market attention. On January 12, Zhifei Biological released its 2025 annual performance forecast, projecting a net...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0077","LU1328615791.USD","LU2148510915.USD","BK0046","BK0196","LU1064131003.USD","LU2580892789.USD","300122","LU1064130708.USD","LU2580892862.HKD","BK0239"],"gpt_icon":0},{"id":"1154670821","title":"Zhifei Biological Projects Over 10.6 Billion Yuan Loss: Why Did Chongqing's Richest Man with Vaccine \"Secret Formula\" Fail?","url":"https://stock-news.laohu8.com/highlight/detail?id=1154670821","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154670821?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:32","pubTimestamp":1768311146,"startTime":"0","endTime":"0","summary":"Investing in stocks requires viewing Golden Unicorn analyst research reports for authoritative, professional, timely, and comprehensive analysis to help you uncover potential thematic opportunities!...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","159646","BK0046","LU2148510915.USD","LU2580892789.USD","BK0239","LU2580892862.HKD","LU1064130708.USD","BK0196","LU1328615791.USD","BK0077","300122","BK0188"],"gpt_icon":0},{"id":"2603157197","title":"Zhifei Biological Products Unit's CA111 injection Enters Phase I Clinical Trials; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603157197","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603157197?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:54","pubTimestamp":1768276493,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products  said CA111 injection, which is developed by its subsidiary Chongqing Chenan Biopharmaceutical, entered phase I clinical trials, according to a Monday disclosure on the Shenzhen bourse.The Chinese biological company's shares rose less than 3% during Tuesday's morning trade.The trial is being conducted in China's Zhejiang Province to test the drug as a treatment for diabetes and weight management.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1328615791.USD","BK0046","LU2580892862.HKD","BK0188","BK0239","LU1064131003.USD","LU2148510915.USD","BK0077","LU1064130708.USD","LU2580892789.USD","300122","BK0196"],"gpt_icon":0},{"id":"1140913655","title":"Zhifei Biological (300122.SZ): CA111 Injection Enters Phase I Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1140913655","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140913655?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:11","pubTimestamp":1768216304,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co.,Ltd. (300122.SZ) announced that it has recently been informed that the CA111 injection, developed by its controlling subsidiary, Chongqing Chen'an...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","LU2148510915.USD","BK0046","LU2580892789.USD","BK0239","LU1328615791.USD","BK0188","300122","BK0196","BK0077","LU1064131003.USD","LU2580892862.HKD"],"gpt_icon":0},{"id":"1114636112","title":"Vaccine Leader Zhifei Biological Products Faces 20 Billion Yuan Inventory, Seeks 10.2 Billion Yuan Lifeline, with Massive Batch of 9-Valent HPV Vaccines Set to Expire This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1114636112","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114636112?lang=en_us&edition=fundamental","pubTime":"2026-01-09 13:51","pubTimestamp":1767937879,"startTime":"0","endTime":"0","summary":"On the evening of January 5, 2026, A-share vaccine leader Chongqing Zhifei Biological Products Co., Ltd. announced plans to apply for medium to long-term loans totaling no more than 10.2 billion...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0046","159646","LU1064131003.USD","LU2580892862.HKD","BK0188","LU1328615791.USD","159645","LU2148510915.USD","LU2580892789.USD","BK0077","LU1064130708.USD","300122","BK0196"],"gpt_icon":0},{"id":"1165664766","title":"471 Shenzhen Market Companies Lead \"Quality and Return Enhancement\" Initiative, Dividend Payout Ratio Rises Nearly 11 Percentage Points in 2 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1165664766","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165664766?lang=en_us&edition=fundamental","pubTime":"2025-12-27 11:31","pubTimestamp":1766806265,"startTime":"0","endTime":"0","summary":"A total of 471 Shenzhen market companies have disclosed their action plans. In February last year, the Shenzhen Stock Exchange officially launched the \"Quality and Return Enhancement\" special...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1734074674.USD","LU1328615791.USD","LU2663582299.SGD","LU2153592121.USD","LU0633140727.USD","LU0823426480.USD","LU1720050803.USD","LU2580892789.USD","BK0239","LU1146622755.USD","301095","LU2328871848.SGD","BK0108","LU2213484517.USD","LU2360107325.USD","BK0152","LU0327786744.USD","BK0214","LU1781817850.SGD","LU1997245177.USD","300476","LU1794554557.SGD","BK0231","LU1688375341.USD","LU0979878070.USD","BK0169","LU1861214812.USD","SGXZ81163826.USD","BK0077","300919","LU0650527681.SGD","LU1934453819.USD","SGXZ49509284.SGD","LU2153591404.USD","002493","LU1820825898.SGD","LU1969619763.USD","BK0197","BK0028","BK0132","IE00B29SXG58.USD","LU0359201612.USD","BK0251","LU0405327148.USD","IE0005HP3H50.USD","LU2580892862.HKD","BK0014","LU1064131003.USD","BK0183","IE00B031HY20.USD","LU2424517915.HKD","002241","LU2289578879.USD","BK0224","LU0605514214.HKD","LU1997245094.SGD","BK0187","BK0188","LU1064130708.USD","LU1023057109.AUD","IE0008368742.USD","LU0594300179.USD","300009","LU1580142542.USD","BK0175","002821","LU0683595622.HKD","BK0046","BK0060","BK0208","BK0026","BK0072","BK0042","BK0264","LU0823426308.USD","LU1242518931.SGD","BK0155","LU1997244956.HKD","LU0084288322.USD","002594","IE0031814852.USD","IE00B031J352.USD","LU0633140560.USD","LU0359202008.SGD","LU1655091616.SGD","LU0405327494.USD","EVS.SI","LU1242518857.USD","300760","LU2348774022.SGD","BK0070","LU2488822045.USD","BK0121","LU0469268626.HKD","LU2348773727.SGD","BK0196","LU1508157978.USD","LU1808992512.USD","000725","BK0109","LU0572944931.SGD","300122","LU1979443071.USD","LU2495084118.USD","LU2148510915.USD","LU0594300419.USD","LU1861219969.SGD"],"gpt_icon":0},{"id":"1165688332","title":"Chongqing Zhifei Biological Products (300122.SZ) Receives Approval for Clinical Trial Application of Modified Ankara Vaccinia Virus (MVA) Monkeypox Attenuated Live Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1165688332","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165688332?lang=en_us&edition=fundamental","pubTime":"2025-12-17 16:48","pubTimestamp":1765961329,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) announced that its wholly-owned subsidiary, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (\"Zhifei Longcom\"), has received the acceptance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","LU2580892862.HKD","LU2580892789.USD","BK0239","300122","BK0046","BK0196","BK0077","BK0188","LU1064130708.USD","LU1064131003.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"1115637782","title":"Chongqing Zhifei Biological Products (300122.SZ): Clinical Trial Application for Recombinant Zoster ZFA01 Adjuvant Vaccine (CHO Cell) Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1115637782","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115637782?lang=en_us&edition=fundamental","pubTime":"2025-11-19 17:40","pubTimestamp":1763545240,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products (300122.SZ) announced that its wholly-owned subsidiary, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (\"Zhifei Longcom\"), has received the acceptance notice...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","LU2580892862.HKD","LU1064130708.USD","LU2580892789.USD","LU2148510915.USD","LU1328615791.USD","BK0188","BK0077","300122","BK0196","BK0046","BK0239","159646"],"gpt_icon":0},{"id":"2582240593","title":"Chongqing Zhifei Biological Products Subsidiary Gets China Nod for Shingles, Chickenpox Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2582240593","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582240593?lang=en_us&edition=fundamental","pubTime":"2025-11-12 18:06","pubTimestamp":1762942019,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved clinical trials for a herpes zoster vaccine developed by Chongqing Zhifei Biological Products (SHE:300122) subsidiary Anhui Zhifei Longcom Biopharmaceut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","LU1064130708.USD","BK0188","LU2580892862.HKD","LU2148510915.USD","LU2580892789.USD","BK0046","300122","LU1328615791.USD","LU1064131003.USD","BK0077","BK0196"],"gpt_icon":0},{"id":"1153620081","title":"Chongqing Zhifei Biological Products (300122.SZ) Receives Acceptance for Clinical Trial Application of Freeze-Dried Varicella Inactivated Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1153620081","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153620081?lang=en_us&edition=fundamental","pubTime":"2025-11-12 17:30","pubTimestamp":1762939839,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) announced that its wholly-owned subsidiary, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (\"Zhifei Longcom\"), has received the acceptance...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","BK0188","300122","BK0077","LU1328615791.USD","LU2148510915.USD","LU2580892789.USD","BK0046","BK0196","BK0239","LU2580892862.HKD","LU1064131003.USD"],"gpt_icon":0},{"id":"1102222580","title":"Chongqing Zhifei Biological Products (300122.SZ) Receives Clinical Trial Approval for Acellular Pertussis-Diphtheria-Tetanus (Component) Combination Vaccine for Adults and Adolescents","url":"https://stock-news.laohu8.com/highlight/detail?id=1102222580","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102222580?lang=en_us&edition=fundamental","pubTime":"2025-11-11 16:56","pubTimestamp":1762851379,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) announced that its wholly-owned subsidiary, Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd., has received approval from the National...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","LU2580892862.HKD","LU2580892789.USD","BK0239","300122","BK0046","BK0196","BK0077","BK0188","LU1064130708.USD","LU1064131003.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"1170484279","title":"Chongqing Zhifei Biological Products Reports Worst Q3 Performance in a Decade Amid Dual Pressures from Failing Agency Model and Weak R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1170484279","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170484279?lang=en_us&edition=fundamental","pubTime":"2025-11-07 17:20","pubTimestamp":1762507257,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co.,Ltd. (Zhifei) has reported its worst third-quarter performance in the past decade. For the first three quarters of 2025, the company's revenue fell 12.06%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0196","LU2580892789.USD","LU1064131003.USD","LU2148510915.USD","LU2580892862.HKD","LU1328615791.USD","300122","BK0077","BK0046","BK0188","LU1064130708.USD"],"gpt_icon":0},{"id":"1187905275","title":"Chongqing Zhifei Biological Products Elects Yang Shilong as Employee Representative Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1187905275","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187905275?lang=en_us&edition=fundamental","pubTime":"2025-10-29 22:21","pubTimestamp":1761747691,"startTime":"0","endTime":"0","summary":"On the evening of October 29, Chongqing Zhifei Biological Products Co., Ltd. (300122) announced that the company held a staff representative meeting on October 28, 2025. After democratic discussion...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","BK0046","LU2148510915.USD","LU2580892789.USD","BK0239","LU2580892862.HKD","LU1064130708.USD","BK0196","LU1328615791.USD","BK0077","300122","BK0188"],"gpt_icon":0},{"id":"2579643905","title":"BRIEF-Zhifei Biological Products' Q3 Net Loss At 601.1 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2579643905","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579643905?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:32","pubTimestamp":1761741171,"startTime":"0","endTime":"0","summary":"BRIEF-Zhifei Biological Products' Q3 Net Loss At 601.1 Million YuanOct 29  - Chongqing Zhifei Biological Products Co Ltd 300122.SZ:SAYS Q3 NET LOSS AT 601.1 MILLION YUAN Source textFurther company coverage: 300122.SZ  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4N3WA1JH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1064131003.USD","BK0196","LU1328615791.USD","BK0077","BK0188","LU2148510915.USD","LU2580892789.USD","LU1064130708.USD","LU2580892862.HKD","300122","BK0046"],"gpt_icon":0},{"id":"2579190566","title":"Chongqing Zhifei Biological Products  Says Q3 Net Loss at 601.1 Mln Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2579190566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579190566?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:32","pubTimestamp":1761741171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4N3WA1JH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2148510915.USD","BK0046","LU1064131003.USD","BK0239","LU1328615791.USD","LU1064130708.USD","LU2580892862.HKD","BK0196","BK0188","BK0077","LU2580892789.USD","300122"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-09-28","address":"重庆市两江新区庆云路1号50层","stockEarnings":[{"period":"1week","weight":-0.0867},{"period":"1month","weight":-0.0977},{"period":"3month","weight":-0.1441},{"period":"6month","weight":-0.2764},{"period":"1year","weight":-0.2895},{"period":"ytd","weight":-0.0843}],"companyName":"重庆智飞生物制品股份有限公司","boardCode":"AI0027","perCapita":"11686股","boardName":"医药制造业","registeredCapital":"239378万元","compareEarnings":[{"period":"1week","weight":0.0083},{"period":"1month","weight":0.0495},{"period":"3month","weight":0.047},{"period":"6month","weight":0.151},{"period":"1year","weight":0.2805},{"period":"ytd","weight":0.0422}],"survey":"　　重庆智飞生物制品股份有限公司的主营业务是疫苗、生物制品研发、生产、销售、推广、配送及进出口。公司的主要产品是预防流脑疫苗、宫颈癌疫苗、肺炎疫苗、流感疫苗、轮状病疫苗。","serverTime":1769436118034,"listedPrice":37.98,"stockholders":"121021人(较上一季度减少1.56%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chongqing Zhifei Biological Products Co.,Ltd.(300122),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Chongqing Zhifei Biological Products Co.,Ltd.(300122) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Chongqing Zhifei Biological Products Co.,Ltd.,300122,Chongqing Zhifei Biological Products Co.,Ltd.股票,Chongqing Zhifei Biological Products Co.,Ltd.股票老虎,Chongqing Zhifei Biological Products Co.,Ltd.股票老虎国际,Chongqing Zhifei Biological Products Co.,Ltd.行情,Chongqing Zhifei Biological Products Co.,Ltd.股票行情,Chongqing Zhifei Biological Products Co.,Ltd.股价,Chongqing Zhifei Biological Products Co.,Ltd.股市,Chongqing Zhifei Biological Products Co.,Ltd.股票价格,Chongqing Zhifei Biological Products Co.,Ltd.股票交易,Chongqing Zhifei Biological Products Co.,Ltd.股票购买,Chongqing Zhifei Biological Products Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chongqing Zhifei Biological Products Co.,Ltd.(300122),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Chongqing Zhifei Biological Products Co.,Ltd.(300122) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction